Related Experiment Video
Updated: May 8, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Compounding for pediatric patients: case reports and formulations.
William Mixon1, Patricia Angelle, Douglas Yoch
1The Compounding Pharmacy, Hickory, North Carolina.
International Journal of Pharmaceutical Compounding
|August 24, 2013
Summary
Compounded pharmaceutical formulations are crucial for pediatric patients when standard medications are unsuitable. These customized treatments ensure successful long-term management for complex disorders requiring tailored supplements and medications.
Area of Science:
- Pediatric pharmacology
- Compounded medications
- Formulation science
Background:
- Commercially available medications may not meet the needs of all pediatric patients.
- Individualized treatment is often necessary for specific pediatric health conditions.
Purpose of the Study:
- To highlight the importance of pharmaceutical compounding in pediatric care.
- To present case reports demonstrating the efficacy of compounded formulations in children.
Main Methods:
- Case series review of five pediatric patients.
- Analysis of long-term therapeutic outcomes using compounded formulations.
Main Results:
- Compounded formulations were essential for successful long-term therapy in all presented cases.
- Customized medications and supplements facilitated management of complex pediatric disorders.
Conclusions:
- Pharmaceutical compounding plays a vital role in pediatric treatment when standard agents are inappropriate.
- Tailored formulations are key to managing pediatric disorders requiring customized medications and supplements.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...